← Leaderboards
Robert Edwards
University Of Pittsburgh At Pittsburgh
$15,028
Attributed
$15,028
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $6.4K · FY2006–07$10K$7.5K$5K$2.5K$0
'06
'07
Funding mix
By agency
NIH$15,028 · 5
By mechanism
M01$15,028 · 5
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Francesmary Modugno$3,651,054
- Chandra Belani$1,686,281
- Steve N Caritis$23,921,687
- Michael T Lotze$5,139,928
- Hideaki Tahara$511,148
Others in their field
Top investigators on “Neoplasm /Cancer Immunotherapy”
- Constance Ann Benson · University Of California, San Diego$84,289,569
- Charles A Coltman · Southwest Oncology Group$65,041,418
- Norman Wolmark · Nsabp Foundation, Inc.$63,095,441
- Robert Turner Schooley · University Of Colorado Denver$42,307,156
- Samuel A Wells · Duke University$32,148,803
- George Wilding · University Of Wisconsin Madison$22,104,400
Research focus
Neoplasm /Cancer ImmunotherapyClinical ResearchHuman SubjectHuman Therapy EvaluationIntraperitoneal InjectionsInterleukin 12Drug Administration Rate /DurationOvary NeoplasmsClinical Trial Phase INeoplasm /Cancer ChemotherapyInterleukin 2FemaleWomen'S HealthRecombinant ProteinsNeoplasm /Cancer Relapse /RecurrenceDrug Screening /EvaluationInjection /InfusionMetastasisDosagePeritoneum NeoplasmGrantFundingDisabilityEnvironment
Grant awards (14)
PAIN RESPONSES AND THE IMMUNE SYSTEM IN RHEUMATOID ARTHRITIS$5,545
M01 · FY2007 · RR · contact PI
PAIN RESPONSES AND THE IMMUNE SYSTEM IN RHEUMATOID ARTHRITIS$6,449
M01 · FY2006 · RR · contact PI
PH1 DOSE ESCALATING STUDY OF RECOMBINANT HUMAN INTERLEUKIN 12$0
M01 · FY2002 · RR
INTERLEUKIN 12 INTRAPERITONEAL INFUSION IN OVARIAN CANCE$0
M01 · FY2002 · RR
PH1 DOSE ESCALATING STUDY OF RECOMBINANT HUMAN INTERLEUKIN 12$0
M01 · FY2002 · RR
INTERLEUKIN 2 INFUSION FOR RECURRENT OVARIAN CANCER$0
M01 · FY2002 · RR
INTERLEUKIN 2 INFUSION FOR RECURRENT OVARIAN CANCER$0
M01 · FY2002 · RR
INTERLEUKIN 12 INTRAPERITONEAL INFUSION IN OVARIAN CANCE$0
M01 · FY2002 · RR
PH1 DOSE ESCALATING STUDY OF RECOMBINANT HUMAN INTERLEUKIN 12$0
M01 · FY2001 · RR
INTERLEUKIN 12 INTRAPERITONEAL INFUSION IN OVARIAN CANCE$0
M01 · FY2001 · RR
INTERLEUKIN 2 INFUSION FOR RECURRENT OVARIAN CANCER$0
M01 · FY2001 · RR
PH1 DOSE ESCALATING STUDY OF RECOMBINANT HUMAN INTERLEUKIN 12$3,034
M01 · FY2000 · RR
INTERLEUKIN 12 INTRAPERITONEAL INFUSION IN OVARIAN CANCE$0
M01 · FY2000 · RR
INTERLEUKIN 2 INFUSION FOR RECURRENT OVARIAN CANCER$0
M01 · FY2000 · RR